The Week in Review: February 9 – February 16, 2018

Friday, February 16, 2018 News Recap: HCV & Heart Disease: Evolving Recognition of Chronic Hepatitis C Infection as a Modifiable Risk Factor for CVD. This article examines the evidence for clinical and subclinical cardiovascular diseases in chronic hepatitis c infection, as well as the effect of treatment on cardiovascular outcomes. News from Around the World: NZ: Thousands of Hepatitis C sufferers unaware a cure is within reach. A Hepatitis...

Evolving Recognition of Chronic Hepatitis C Infection as a Modifiable Risk Factor for CVD

Many studies have identified extrahepatic manifestation of chronic hepatitis C virus (HCV) infection, including associations with lymphoproliferative disorders, diabetes mellitus, and renal disease. Increasingly, data have amassed exploring whether HCV infection acts as an independent risk factor for cardiovascular diseases. Evidence for Subclinical Cardiovascular Diseases in Chronic Hepatitis C Infection A recent review by Babiker et al published in the

The Week in Review: August 11 – August 18, 2017

Friday, August 18, 2017 Canada Great news in Canada. Two new drug regimens have been approved:  Vosevi from Gilead is a pangenotypic for retreatment of those who have failed previous DAA therapy Gilead Receives Approval in Canada for VOSEVI™ (Sofosbuvir/Velpatasvir/Voxilaprevir) for Re-treatment of Certain Patients with Chronic Hepatitis C Virus (HCV) Infection. And MAVIRET from AbbVie is the first and only 8-week, pan-genotypic treatment for hepatit...

Hepatitis C Virus Infection and Cardiovascular Disease Risk

Patients with HCV infection have a higher risk for carotid atherosclerosis and cerebrocardiovascular events. Hepatitis C virus (HCV) infection is a common cause of chronic liver disease worldwide and is associated with greater mortality compared with that in the general population or even mortality associated with HIV infection. Although liver disease and liver cirrhosis account for the bulk of HCV-related disease burden and deaths, it is becoming increas

Patients with HIV, hepatitis C present unique considerations for cardiologists

The link between CVD (cardiovascular disease) and HIV and hepatitis C virus is complex. Progress has been made in recent years regarding diagnosis and treatment, but unanswered questions remain. Patients with HIV and hepatitis C virus are living longer due to breakthroughs in treatment, leading cardiologists to play a larger role in the associated CVDs that may arise. “The community is learning that HIV-infected individuals are living longer, and because

The Week in Review: Feb 10, 2017 – Feb 17, 2017

Friday, February 17, 2017 News Recap HCV & Heart Disease More and more I am hearing that people who have just finished treatment for HCV have had a stroke!  Our community really needs to know that hepatitis C is an independent risk factor for various kinds of heart disease: cerebrovascular events (strokes), and ischemic heart disease caused by atherosclerosis (plaque build-up in the arteries – particularly the coronary and carotid arteries, whic...

Cardiovascular disease risk is higher for people with hepatitis C

People with hepatitis C are at higher risk of dying from cardiovascular disease suffering a stroke or developing cardiovascular problems than people with similar risk factors for heart disease who do not have hepatitis C, a meta-analysis of published studies has shown.The findings, published in the January 2016 edition of Gastroenterology, come from a meta-analysis of 22 epidemiological studies conducted by Salvatore Petta and colleagues at the University